How IMI works

At the Innovative Medicines Initiative (IMI), we work to improve health by speeding up the development of innovative medicines, particularly in areas where there is an unmet medical or social, public health need. We do this by facilitating collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. This page explains how our top level objectives, as set out in the IMI1 and IMI2 legislation and the Strategic Research Agenda guide the choice of topics for Calls for proposals and, ultimately, the selection of projects.

 

IMI_CT_850_242%20(2).jpg